Date:8/7/2012

ring described above. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including, among others, the ability to manage successfully and complete the public offering, general economic and/or market conditions and the factors set forth in the Company's filings with the SEC, including the Company's Annual Report on Form 10-K for the year ended December 31, 2011, the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2012, the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2012 and the prospectus supplement related to this public offering. The Company undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law.

'/>"/>

SOURCE Solta Medical, Inc. Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock
2. Solta Medical, Inc. Announces Proposed Public Offering of Common Stock
3. Solta Medical Reports Second Quarter Results
4. Solta Medical to Present at the JMP Securities Healthcare Conference
5. Solta Medical Reports First Quarter Results
6. BioDrain Medical, Inc. Implements Initiatives to Position Itself for Sustained Growth
7. Cook Medical, Zimmer, Pro-Dex & J&J to Share Innovative Social Media Approaches to Marketing Device Products in Minneapolis
8. NexGen Biomedical, Inc. Provides New Insights Into Jett Travoltas Seizure Related Death
9. Nonin Medical, Inc. Announces U.S. Market Release of EQUANOX™ Advance Model 8004CB Series Sensor for Neonatal, Pediatric Patients
10. TriReme Medical, Inc. Receives FDA Approval for Glider™ PTCA Catheter
11. ICU Medical, Inc. Plans to "Vigorously Seek to Collect Damages" in wake of Patent Infringement Victory Over RyMed Technologies